According to Antares Pharma, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:11 PM, company President & CEO, Apple Robert F disclosed selling 5,519 shares at a cost of $4.75. At the time of this transaction (Feb 17), this trade was worth $26,215 in […]
According to Fibrogen Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:10 PM, company Director, Kurkijarvi Kalevi disclosed selling 6,000 shares at a cost of $52.40. At the time of this transaction (Feb 17), this trade was worth $314,383 in total. As of Feb […]
According to Antares Pharma, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:08 PM, company Director, Jacob Leonard S disclosed selling 15,321 shares at a cost of $5.05. At the time of this transaction (Feb 18), this trade was worth $77,371 in total. As […]
According to Antares Pharma, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:07 PM, company EVP General Counsel, Secretary, Graham Peter J disclosed selling 45,000 shares at a cost of $4.93. At the time of this transaction (Feb 18), this trade was worth $221,650 […]
According to Quotient Technology Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:16 PM, company Director, Gessow Andrew J disclosed buying 5,000 shares at a cost of $11.98. At the time of this transaction (Feb 18), this trade was worth $59,900 in total. As […]
According to Decibel Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:09 PM, company Director, Orbimed Advisors Llc disclosed buying 1,666,666 shares at a cost of $18.00. At the time of this transaction (Feb 17), this trade was worth $29,999,988 in total. As […]
According to Decibel Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:59 PM, company Director, Foy Matthew disclosed buying 150,000 shares at a cost of $18.00. At the time of this transaction (Feb 17), this trade was worth $2,700,000 in total. As of […]
According to Decibel Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:56 PM, company 10% Owner, Casdin Partners Master Fund, L disclosed buying 575,000 shares at a cost of $18.00. At the time of this transaction (Feb 17), this trade was worth $10,350,000 […]
According to Decibel Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:50 PM, company Director, Thompson Peter A. disclosed buying 1,666,666 shares at a cost of $18.00. At the time of this transaction (Feb 17), this trade was worth $29,999,988 in total. As […]
According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:21 PM, company Director, Popovits Kimberly J disclosed buying 5,300 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $84,800 in total. As […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
